Cargando…
Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health, Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431436/ https://www.ncbi.nlm.nih.gov/pubmed/37600863 http://dx.doi.org/10.1097/AS9.0000000000000251 |
| _version_ | 1785091202063794176 |
|---|---|
| author | Famularo, Simone Donadon, Matteo Cipriani, Federica Aldrighetti, Luca Trevisani, Franco Torzilli, Guido |
| author_facet | Famularo, Simone Donadon, Matteo Cipriani, Federica Aldrighetti, Luca Trevisani, Franco Torzilli, Guido |
| author_sort | Famularo, Simone |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431436 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Wolters Kluwer Health, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104314362023-08-18 Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” Famularo, Simone Donadon, Matteo Cipriani, Federica Aldrighetti, Luca Trevisani, Franco Torzilli, Guido Ann Surg Open Letter to the Editor Wolters Kluwer Health, Inc. 2023-03-13 /pmc/articles/PMC10431436/ /pubmed/37600863 http://dx.doi.org/10.1097/AS9.0000000000000251 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Letter to the Editor Famularo, Simone Donadon, Matteo Cipriani, Federica Aldrighetti, Luca Trevisani, Franco Torzilli, Guido Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title | Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title_full | Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title_fullStr | Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title_full_unstemmed | Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title_short | Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” |
| title_sort | response to: “comment on hepatectomy versus sorafenib in advanced nonmetastatic hepatocellular carcinoma” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431436/ https://www.ncbi.nlm.nih.gov/pubmed/37600863 http://dx.doi.org/10.1097/AS9.0000000000000251 |
| work_keys_str_mv | AT famularosimone responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma AT donadonmatteo responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma AT ciprianifederica responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma AT aldrighettiluca responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma AT trevisanifranco responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma AT torzilliguido responsetocommentonhepatectomyversussorafenibinadvancednonmetastatichepatocellularcarcinoma |